Abovitz Rony A 4

4 · MAKO Surgical Corp. · Filed Dec 28, 2009

Form 4

Period: 2009-12-23

SVP, Chief Technology Officer

Transactions

Exercise/Conversion
Employee Stock Option (Right to Buy)
2009-12-24−3,600→ 71,909 total
Exercise: $1.27Exp: 2015-07-18→ Common Stock (3,600 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2009-12-28−22,300→ 49,609 total
Exercise: $1.27Exp: 2015-07-18→ Common Stock (22,300 underlying)
Exercise/Conversion
Common Stock
2009-12-23$1.27/sh+6,999$8,907→ 9,866 total
Sale
Common Stock
2009-12-24$10.87/sh−3,600$39,120→ 0 total
Exercise/Conversion
Common Stock
2009-12-28$1.27/sh+22,300$28,379→ 22,300 total
Sale
Common Stock
2009-12-28$11.20/sh−22,300$249,742→ 0 total
Exercise/Conversion
Common Stock
2009-12-24$1.27/sh+3,600$4,581→ 3,600 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2009-12-23−6,999→ 75,509 total
Exercise: $1.27Exp: 2015-07-18→ Common Stock (6,999 underlying)
Exercise/Conversion
Common Stock
2009-12-23$0.67/sh+2,867$1,911→ 2,867 total
Sale
Common Stock
2009-12-23$10.89/sh−9,866$107,462→ 0 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2009-12-23−2,867→ 0 total
Exercise: $0.67From: 2004-12-16Exp: 2014-12-16→ Common Stock (2,867 underlying)

Footnotes (4)

[F1]The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $10.68 per share to $11.04 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
[F2]The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $10.76 per share to $10.98 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
[F3]The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $10.89 per share to $11.38 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
[F4]The option became exercisable over four years as follows: twenty-five percent (25%) on July 18, 2006, the first anniversary of the date on which the option was granted, and the remaining seventy-five percent (75%) ratably over the thirty-six (36) months thereafter.

Documents

1 file